- Home
- Gastroenterology
- A Phase 3 Trial of Long-Term Naloxegol Use in Patients with Opioid-Induced Constipation
4w3 min read
Medical Article
Introduction Opioid-induced constipation (OIC) is one of the most common and distressing adverse effects of long-term opioid therapy in patients with chronic noncancer pain. Conventional management strategies, including dietary modification and laxatives, often provide limited relief. Naloxegol, an oral peripherally acting μ-opioid receptor antagon

A Phase 3 Trial of Long-Term Naloxegol Use in Patients with Opioid-Induced Constipation
877 Reached
Similar Content

Woman presented with Fever of Unknown Origin
7731 Reached93 Comments19 Likes

How Physicians Should Manage Stress?
35339 Reached151 Comments202 Likes

Male with Jaw Pain and Abdominal Bloating
790 Reached24 Comments26 Likes

Case of Adolescent with Severe Macrocytic Anaemia
52903 Reached502 Comments51 Likes

Study evaluating Effectiveness of Bacillus clausii for Treatment of Rotavirus Infection
1303 Reached4 Comments6 Likes
